Asset Details
Do you wish to reserve the book?
Metabolic syndrome and increased susceptibility to renal cell carcinoma – a meta-analysis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Metabolic syndrome and increased susceptibility to renal cell carcinoma – a meta-analysis
Do you wish to request the book?
Metabolic syndrome and increased susceptibility to renal cell carcinoma – a meta-analysis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Metabolic syndrome and increased susceptibility to renal cell carcinoma – a meta-analysis
2025
Overview
Background
Metabolic syndrome (MetS) has been demonstrated to be associated with various types of cancer, but its specific relationship with kidney cancer remains inconclusive. Therefore, this study conducts a Meta-analysis to systematically evaluate the potential link between metabolic syndrome and the risk of kidney cancer development.
Methods
Observational studies were retrieved from PubMed, Embase, Cochrane Library, and Web of Science. Two independent reviewers extracted study characteristics and assessed the quality of the studies. A random-effects model was employed to account for heterogeneity, and subgroup analyses were conducted to explore the impact of study characteristics on the results. Publication bias was evaluated using funnel plot symmetry and Egger’s regression test.
Results
Six studies were included, with 10 results extracted for the Meta-analysis. The findings indicated that MetS is an independent risk factor for kidney cancer (HR: 1.44, 95% CI: 1.31–1.59,
P
< 0.001). Heterogeneity between studies was significant (Cochran’s Q test,
P
< 0.001; I
2
= 83.7%), indicating substantial variability. Subgroup analyses revealed consistent associations across gender, follow-up duration, and MetS diagnostic criteria (
P
> 0.05), but significant variations by race and study design (
P
< 0.05). The funnel plot appeared symmetrical, and Egger’s regression test (
P
= 0.425) confirmed a low risk of publication bias.
Conclusion
MetS is independently associated with an increased susceptibility to RCC in the adult population, although the strength of this association varies across different study designs and regions due to the observed heterogeneity.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Analysis
/ Cancer
/ Carcinoma, Renal Cell - diagnosis
/ Carcinoma, Renal Cell - epidemiology
/ Complications and side effects
/ Diabetes
/ Humans
/ Kidney Neoplasms - diagnosis
/ Kidney Neoplasms - epidemiology
/ Medicine
/ Metabolic Syndrome - complications
/ Metabolic Syndrome - diagnosis
/ Metabolic Syndrome - epidemiology
/ Obesity
/ Prostate
/ Tumors
